Zobrazeno 1 - 10
of 40
pro vyhledávání: '"J P Im"'
Publikováno v:
Journal of Crohn's and Colitis. 17:i325-i326
Background Diagnostic delay in inflammatory bowel disease (IBD) was frequent and may be associated with poor outcomes. The aim of this study was to develop a predictive model for early diagnosis of IBD. Methods From March 2020 to January 2022, a 15-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ce55a7f325c631a8b964704fad45e7e
https://doi.org/10.1093/ecco-jcc/jjac190.0298
https://doi.org/10.1093/ecco-jcc/jjac190.0298
Autor:
S K Park, H Kim, S Kim, C W Lee, Y Jung, C H Choi, S B Kang, T O Kim, K B Bang, J Chun, J M Cha, J P Im, K S Ahn, D I Park
Publikováno v:
Journal of Crohn's and Colitis. 17:i415-i415
Background Although the gut microbiome dysbiosis have independently been shown to be associated with inflammatory bowel disease (IBD), less is known about the relationship between oral microbiota and IBD. This study aimed to elucidate unique microbio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::360aa96b2dbfe72431a28dc767c90a1e
https://doi.org/10.1093/ecco-jcc/jjac190.0396
https://doi.org/10.1093/ecco-jcc/jjac190.0396
Publikováno v:
Journal of Crohn's and Colitis. 17:i1035-i1035
Background Blautia is a genus of anaerobic bacteria known as having probiotic properties in several studies. The aim of this study was to investigate the role of Blautia obeum in inflammatory bowel disease which has not yet been elucidated. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c14348bfc7b4ec7b9219c43a4f22d6ef
https://doi.org/10.1093/ecco-jcc/jjac190.1056
https://doi.org/10.1093/ecco-jcc/jjac190.1056
Publikováno v:
Journal of Crohn's and Colitis. 17:i373-i373
Background Inflammatory bowel disease (IBD) has been associated with an increased risk of migraine in a nationwide cohort sample analysis, but there is no evidence on the impact of migraine on the development of IBD The aim of this study was to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96ad49609c03cfd7d994daa80af6c8cc
https://doi.org/10.1093/ecco-jcc/jjac190.0349
https://doi.org/10.1093/ecco-jcc/jjac190.0349
Publikováno v:
Journal of Crohn's and Colitis. 16:i335-i336
Background There are a few studies about the relationship between inflammatory bowel disease (IBD) and atopic dermatitis (AD). It implicates that both diseases have common pathophysiologic mechanism and are able to affect each other. However, little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57bb7656cb8c4632aa147f12a4ce4007
https://doi.org/10.1093/ecco-jcc/jjab232.437
https://doi.org/10.1093/ecco-jcc/jjab232.437
Publikováno v:
Journal of Crohn's and Colitis. 16:i199-i200
Background Icariin is a natural flavonoid glucoside from plants in Epimedium family, known to have anti-oxidative and anti-inflammatory activities. This study investigated the effects of Icariin on nuclear factor-kappa B (NF-ĸB) signaling pathway in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe8fcd1d9b0304cfc6198994aa599e2
https://doi.org/10.1093/ecco-jcc/jjab232.232
https://doi.org/10.1093/ecco-jcc/jjab232.232
Publikováno v:
Journal of Crohn's and Colitis. 16:i213-i214
Background Both inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) are inflammatory diseases but there was little previous study that demonstrate the IBD severity and outcome in IBD patients with concomitant AS. Methods Patients’ reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf462596a517372b18211d5e8537923f
https://doi.org/10.1093/ecco-jcc/jjab232.253
https://doi.org/10.1093/ecco-jcc/jjab232.253
Autor:
S Shin Shin, S Y Kim, S J Park, J P Im, H J Kim, K M Lee, J W Kim, S A Jung, J Lee, S B Kang, S J Shin, E S Kim, Y S Kim, T O Kim, H S Kim, D I Park, H K Kim, Y H Kim, D Teng, J H Kim, W Kim, M Saeed, J M Moon, K Kim, C H Choi, H K Choi
Publikováno v:
Journal of Crohn's and Colitis. 16:i225-i225
Background Tumor necrosis factor (TNF) antagonists are recommended for patients with ulcerative colitis (UC) for the effectiveness in inducing and maintaining clinical remission. We investigated the altered fecal metabolites and lipids by anti-TNF tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd4e155dc4130e69fa1f5c6177c28d5a
https://doi.org/10.1093/ecco-jcc/jjab232.272
https://doi.org/10.1093/ecco-jcc/jjab232.272
Publikováno v:
Journal of Crohn's and Colitis. 16:i584-i584
Background In comparison with the general population, patients with Crohn’s disease (CD) are at higher risk of developing small bowel adenocarcinoma (SBA). However, with low prevalence of SBA, data regarding the impact of CD on survival are lacking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccdf8ea2dca7d6ae60da0eb626285de3
https://doi.org/10.1093/ecco-jcc/jjab232.802
https://doi.org/10.1093/ecco-jcc/jjab232.802
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.